Navigation Links
Potential Brain Cancer Drug for Children May Damage Bones
Date:3/10/2008

ole for HhAntag as a treatment for medulloblastoma. "The effects we see in mice may be less dramatic in children, and there may be methods of delivering this drug directly to brain tissue, while avoiding bones. Alternatively, we might discover other drugs that act on the hedgehog pathway but selectively target brain tissue." Another approach, he adds, may be to use HhAntag only in older children who have already completed their growth, or in the admittedly small proportion of medulloblastoma patients who are adults.

"Signal transduction inhibitors such as this drug may still prove beneficial in treating children's cancers, but our findings raise questions about possible adverse effects during childhood development," said Curran.

The National Institutes of Health supported the study. The biotech company Genentech provided supplies of the drug used in the research. Curran's co-authors were Hiromichi Kimura, formerly of St. Jude's Children's Research Hospital; and Jessica M.Y. Ng, of The Children's Hospital of Philadelphia.

About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking third in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 430-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.

Contact: John Ascenzi

Phone: (267) 426-6055


'/>"/>
SOURCE The Children's Hospital of Philadelphia
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. UCLA study identifies designer estrogen as potential MS drug
3. Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults
4. Common abdominal pain may be due to a potentially treatable newly recognized inflammatory reaction
5. Potential new approach to treat cognitive impairments in schizophrenia
6. Nosespray vaccine using aloe vera has exciting potential, researcher says
7. Network approach identifies potential breast cancer susceptibility gene
8. Liver fibrosis will be treated by a potential target
9. Researchers study potential health benefits of natural chemicals in muscadine grape seeds
10. Jefferson researchers find stem cells in degenerating spinal discs, potential for repair
11. China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... new study provides welcome news for patients with a ... , The condition is estimated to impact 62,000 Canadians ... abnormal clot forms in a vein and restricts the ... cases, the clot may detach from its point of ... causing a potentially fatal condition known as a pulmonary ...
(Date:12/6/2009)... Belluck & Fox, LLP says dangerous substances such as asbestos have ... ... New York, NY (PRWEB) December 6, 2009 -- As parents ... alert to reports of recalls due to lead paint or asbestos ... 230,000 children visit hospital emergency rooms each year due to toy-related ...
(Date:12/5/2009)... 5 ,, What: Cuts for a ... in the fight against cancer and other terminal illnesses affecting ... donated to St. Jude Children,s Research Hospital. Guests will enjoy ... delectable and savory Vietnamese restaurant in Falls Church for all ...
(Date:12/5/2009)... Leukemia and myeloproliferative disorders are serious and ... the 51st Annual Meeting of the American Society ... improved diagnostic methods for patients suffering from acute ... leukemia, and myelofibrosis that are based on a ...
(Date:12/5/2009)... Center helps companies develop and test their cleaning processes. The technology ... of industries and solve problems for customers relating to cleaning parts, ... ... 2009 -- Midbrook, Inc , a Jackson, MI-based company, is ...
Breaking Medicine News(10 mins):Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3
... DALLAS, Oct. 29 Crdentia Corp. (OTC Bulletin,Board: ... it has,completed a private placement of a $5 ... be used for working capital and strategic,initiatives. In ... growth throughout the Sun Belt and enhancing its ...
... problem, most don,t get eyes examined, new ... nationwide survey shows, ... set the clocks back an hour on November 4 and see ... drivers,passengers, and pedestrians about what people may not be seeing while,driving ...
... /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE:,WX), China,s premier provider ... Ge Li, the company,s Chairman and Chief Executive,Officer ... Year (EOY) China,2007 Award. This prestigious award was ... on October 26 in the China World Hotel, ...
... higher blood pressure and are at greater risk of ... sleep quality and exhibit a smaller nighttime decrease in ... dipping. , This ethnic difference in blood pressure dipping ... risk of hypertension, says Dr. Joel Hughes, Kent State ...
... Docuscan System with Digital Pen Technology Allows Hospitals, ... Capture Patient Information, PHILADELPHIA, Oct. 29 ... Conference, Pearson debuted the,Docuscan Patient Registration system, an ... valuable time and,reducing the chance of data entry ...
... they ,Think About Their Drink, ST. LOUIS, Oct. 29 , WHO: ... About Your Drink Family Challenge ... photo contest by submitting a ... part of a nationwide education campaign, the nation,s ...
Other Medicine News:Health News:Crdentia Announces Completion of $5M Financing 2Health News:Crdentia Announces Completion of $5M Financing 3Health News:Blinded by the Light? Vision Problems and Visual Discomfort Make Driving in the Dark Difficult, Uncomfortable for Most Americans 2Health News:Blinded by the Light? Vision Problems and Visual Discomfort Make Driving in the Dark Difficult, Uncomfortable for Most Americans 3Health News:Blinded by the Light? Vision Problems and Visual Discomfort Make Driving in the Dark Difficult, Uncomfortable for Most Americans 4Health News:WuXi PharmaTech (NYSE: WX) CEO Honored with Ernst & Young Entrepreneur Of The Year China 2007 Award 2Health News:WuXi PharmaTech (NYSE: WX) CEO Honored with Ernst & Young Entrepreneur Of The Year China 2007 Award 3Health News:Pearson Introduces 'Smart' Technology for Collecting Patient Registration Information 2Health News:Pearson Introduces 'Smart' Technology for Collecting Patient Registration Information 3Health News:MilkPEP: St. Louis Family Wins Nationwide got milk? Contest 2Health News:MilkPEP: St. Louis Family Wins Nationwide got milk? Contest 3
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Amgen Inc. ... three studies on the safety and efficacy of ... (MDS). MDS is a pre-leukemic condition in which ... are unable to mature normally, thereby limiting their ... can lead to low platelet counts. The results ...
(Date:12/4/2009)... A simple, inexpensive computer tool that measures volume ... lungs picked up by a CT scanner can rule ... doctors to diagnose true cancers with fewer, less expensive ... ,, The new diagnostic guidelines are described in a ...
(Date:12/4/2009)... are Transported ,, PHILADELPHIA, Dec. 4 ... American Red Cross are hard at work educating the ... that could potentially put Philadelphia,s blood supply at risk. ... set up a picket line yesterday when their issues ...
Breaking Medicine Technology:Nplate(R) Data From MDS Studies Presented at ASH 2Nplate(R) Data From MDS Studies Presented at ASH 3Nplate(R) Data From MDS Studies Presented at ASH 4Nplate(R) Data From MDS Studies Presented at ASH 5Nplate(R) Data From MDS Studies Presented at ASH 6Nplate(R) Data From MDS Studies Presented at ASH 7Nplate(R) Data From MDS Studies Presented at ASH 8Nplate(R) Data From MDS Studies Presented at ASH 9Nplate(R) Data From MDS Studies Presented at ASH 10European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2MicroMass Hires Veteran Relationship Marketing Strategist Richard Patterson As VP Group Account Director 50422 1MicroMass Hires Veteran Relationship Marketing Strategist Richard Patterson As VP Group Account Director 50422 2MicroMass Hires Veteran Relationship Marketing Strategist Richard Patterson As VP Group Account Director 50422 3Delawares Partnership to Fight Chronic Disease Breakfast Highlights Promising Practices in Managing Chronic Disease Provides Solutions for Reduced Spe 50419 1Delawares Partnership to Fight Chronic Disease Breakfast Highlights Promising Practices in Managing Chronic Disease Provides Solutions for Reduced Spe 50419 2Lupin Expands Branded Play 50416 1Lupin Expands Branded Play 50416 2Lupin Expands Branded Play 50416 3
... 7 Taligen Therapeutics Inc.,today announced that in ... were presented at the XXII International Complement Workshop ... in,several animal models of complement-mediated diseases., "These ... studies,presented at the conference, reveal the deep expertise ...
... Planned 15 Patient Cohort Enrolled in Stage A of ... Combination With Carboplatin and Paclitaxel -, TUSTIN, Calif., ... a clinical stage biopharmaceutical,company developing monoclonal antibodies for the ... announced that it has completed,enrollment in the first stage ...
Other Medicine Technology:In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: